Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Choy

Showing results (11-20 of 357) with videos related to

Pageof 36
Sort By:
Rheumatology (Oxford, England)|July 1, 2004
Two is better than one? Combination therapy in rheumatoid arthritisE H Choy
Rheumatology (Oxford, England)|December 4, 2018
Clinical significance of Janus Kinase inhibitor selectivityErnest H Choy
Rheumatology (Oxford, England)|January 31, 2019
Clinical significance of Janus Kinase inhibitor selectivityErnest H Choy
Clinical and Experimental Rheumatology|July 17, 2009
Selective modulation of T-cell co-stimulation: a novel mode of action for the treatment of rheumatoid arthritisE H Choy
Rheumatology (Oxford, England)|November 5, 2019
Effect of biologics and targeted synthetic disease-modifying anti-rheumatic drugs on fatigue in rheumatoid arthritisErnest H Choy
Seminars in Oncology|October 18, 2001
The current state of paclitaxel and radiation in the combined-modality therapy of non-small cell lung cancerH Choy, R MacRae
Hawaii Dental Journal|December 13, 2006
Children, sports injuries & mouthguardsMelvin M H Choy
Clinical Lung Cancer|January 22, 2004
A phase I trial of outpatient weekly irinotecan/carboplatin and concurrent radiation for stage III unresectable non small-cell lung cancer: a Vanderbilt-Ingram Cancer Center Affiliate Network TrialA Chakravarthy, H Choy
Seminars in Radiation Oncology|April 21, 1999
Single-agent paclitaxel and radiation for non-small cell lung cancerW Akerley, H Choy
Seminars in Oncology|August 1, 1995
Preliminary analysis of a phase II study of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancerH Choy, H Safran
Pageof 36

Showing results (11-20 of 357) with videos related to

Sort By:
Pageof 36
Rheumatology (Oxford, England)|July 1, 2004
Two is better than one? Combination therapy in rheumatoid arthritisE H Choy
Rheumatology (Oxford, England)|December 4, 2018
Clinical significance of Janus Kinase inhibitor selectivityErnest H Choy
Rheumatology (Oxford, England)|January 31, 2019
Clinical significance of Janus Kinase inhibitor selectivityErnest H Choy
Clinical and Experimental Rheumatology|July 17, 2009
Selective modulation of T-cell co-stimulation: a novel mode of action for the treatment of rheumatoid arthritisE H Choy
Rheumatology (Oxford, England)|November 5, 2019
Effect of biologics and targeted synthetic disease-modifying anti-rheumatic drugs on fatigue in rheumatoid arthritisErnest H Choy
Seminars in Oncology|October 18, 2001
The current state of paclitaxel and radiation in the combined-modality therapy of non-small cell lung cancerH Choy, R MacRae
Hawaii Dental Journal|December 13, 2006
Children, sports injuries & mouthguardsMelvin M H Choy
Clinical Lung Cancer|January 22, 2004
A phase I trial of outpatient weekly irinotecan/carboplatin and concurrent radiation for stage III unresectable non small-cell lung cancer: a Vanderbilt-Ingram Cancer Center Affiliate Network TrialA Chakravarthy, H Choy
Seminars in Radiation Oncology|April 21, 1999
Single-agent paclitaxel and radiation for non-small cell lung cancerW Akerley, H Choy
Seminars in Oncology|August 1, 1995
Preliminary analysis of a phase II study of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancerH Choy, H Safran
Pageof 36